- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT04838873
Trial of Open Versus Laparoscopic Radical Cystectomy at a Laparoscopic Naive Center
8. april 2021 opdateret af: Ahmed Abdelbary Ali, Cairo University
Randomised Controlled Trial of Open Versus Laparoscopic Radical Cystectomy at a Laparoscopic Naive Center
This study is a prospective randomised controlled study of urinary bladder cancer patients presented to urology unit at National Cancer Institute; Cairo University.
Studieoversigt
Status
Afsluttet
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
The study will randomise 60 patients to one of two arms; laparoscopic-assisted radical cystectomy and open radical cystectomy.
The focus of the study will be a comparison of both approaches on the patients' peri-operative outcome.
Undersøgelsestype
Interventionel
Tilmelding (Faktiske)
60
Fase
- Ikke anvendelig
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
-
Cairo, Egypten, 11796
- National Cancer Institute
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
30 år til 80 år (Voksen, Ældre voksen)
Tager imod sunde frivillige
Ingen
Køn, der er berettiget til at studere
Alle
Beskrivelse
Inclusion Criteria:
- Patients with transitional cell carcinoma, squamous cell carcinoma and urinary bladder adenocarcinoma.
- Patients fit for surgery (ECOG Performance Status 0,1).
Exclusion Criteria:
- Patients with medical comorbidities that preclude surgical management or minimally invasive techniques.
- Patients with advanced hydronephrosis or renal failure.
- Patients refusing surgery.
- Patients with urinary bladder cancer invading bladder neck or prostatic urethra.
- Patients with metastatic urinary bladder cancer.
- Patients who received prior pelvic radiotherapy.
- Patients refusing randomization and/or participation in the trial.
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
---|---|
Aktiv komparator: Open Radical Cystectomy
Standard open radical cystectomy.
|
Standard open radical cystectomy and urinary diversion
|
Eksperimentel: Laparoscopic-assisted radical cystectomy.
|
Laparoscopic-assisted radical cystectomy and extracorporeal urinary diversion
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Operative time
Tidsramme: During surgery
|
OR time as measured in minutes, divided into time required to perform the cystectomy, lymph node dissection, and urinary diversion.
|
During surgery
|
Blood loss
Tidsramme: During surgery
|
EBL as measured in millilitres, including the effluent from the suction canister as well as estimates of the gauze swabs.
|
During surgery
|
Length of hospital stay
Tidsramme: Immediate post-operative period.
|
LOS as measured in days
|
Immediate post-operative period.
|
Time to oral intake
Tidsramme: Immediate post-operative period
|
Measured in days
|
Immediate post-operative period
|
Conversion rate
Tidsramme: During surgery
|
Rate of conversion from laparoscopy to open surgery
|
During surgery
|
Re-admission rate.
Tidsramme: Intra-operative to sixth months.
|
Re-hospitalization requirement.
|
Intra-operative to sixth months.
|
Opioid requirements.
Tidsramme: During surgery through first post-operative week.
|
Requirement, dose and duration of narcotic analgesia.
|
During surgery through first post-operative week.
|
Visceral injury
Tidsramme: During surgery
|
Any organ injury encountered during the operation.
|
During surgery
|
Urine leak
Tidsramme: Up to 4 weeks
|
Leakage of urine from urinary enteric anastomosis
|
Up to 4 weeks
|
Wound dehiscence, infection.
Tidsramme: Up to 4 weeks
|
Wound gaping, evisceration or infection.
|
Up to 4 weeks
|
Enteric fistula
Tidsramme: Up to 4 weeks
|
Leakage of intestinal contents due to failure of entero-enteric anastomosis
|
Up to 4 weeks
|
Sepsis
Tidsramme: Up to 4 weeks
|
Infection triggering a systematic immune response
|
Up to 4 weeks
|
Venous thromboembolism
Tidsramme: Up to 2 months
|
DVT or pulmonary embolism
|
Up to 2 months
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
pT stage
Tidsramme: Within 10 days post surgery.
|
Pathologic tumor stage (Stage 1, stage 2, stage 3 or stage 4)
|
Within 10 days post surgery.
|
Lymph node retrieval
Tidsramme: Within 10 days post surgery.
|
Number of lymph nodes retrieved by open versus laparoscopic approaches.
|
Within 10 days post surgery.
|
pN stage
Tidsramme: Within 10 days post surgery.
|
Lymph node metastasis (positive or negative), and number of positive nodes if present.
|
Within 10 days post surgery.
|
Surgical margins
Tidsramme: Within 10 days post surgery
|
Positive margins or negative margins.
Location of positive margins (Urethral, ureteric)
|
Within 10 days post surgery
|
Histological grade
Tidsramme: Within 10 days post surgery
|
Low grade, intermediate grade or high grade
|
Within 10 days post surgery
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Efterforskere
- Ledende efterforsker: Hatem Aboulkassem, M.D., Ph.D., National Cancer Institute, Cairo University
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Faktiske)
24. januar 2019
Primær færdiggørelse (Faktiske)
1. juli 2019
Studieafslutning (Faktiske)
30. december 2020
Datoer for studieregistrering
Først indsendt
30. marts 2021
Først indsendt, der opfyldte QC-kriterier
8. april 2021
Først opslået (Faktiske)
9. april 2021
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
9. april 2021
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
8. april 2021
Sidst verificeret
1. april 2021
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- SO1901-31004
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
INGEN
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ingen
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ingen
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Open radical cystectomy
-
Manisa Celal Bayar UniversityAfsluttet
-
University of Wisconsin, MadisonAfsluttetMentalt helbredForenede Stater
-
Trakya UniversityAfsluttetPerfusionsindeks | En-lunge ventilation | Hypoxæmi under operation | Iltreserveindeks | Pleth VariabilitetsindeksKalkun
-
Case Comprehensive Cancer CenterSuspenderetOndartet neoplasma i prostataForenede Stater
-
City University of New York, School of Public HealthNational Institute on Minority Health and Health Disparities (NIMHD)RekrutteringTest acceptabilitet/brugbarhed af en fysisk aktivitetsapp udviklet til afroamerikanske kvinderForenede Stater
-
PfizerPfizerRekrutteringSeglcellesygdomForenede Stater, Nigeria
-
Universitätsklinikum Hamburg-EppendorfAfsluttet
-
Cedars-Sinai Medical CenterMasimo CorporationAfsluttetStørre rygsøjleoperationForenede Stater
-
OrphAI TherapeuticsAfsluttetAkut myeloid leukæmi | OnkologiForenede Stater